SZSE Ticker: 300396

Dirui Industrial Co., Ltd.

迪瑞医疗科技股份有限公司

迪瑞医疗

DIRUI

Listing Date: 2014-09-10

Board: GEM

Industry Classification: Manufacturing

Central Bureau Observation of Nucleic Acid Testing①｜The demand for new crown testing has changed from strong to weak, and the changes in the IVD industry and the new situation 21 Economic Net

Central Bureau Observation of Nucleic Acid Testing①｜The demand for new crown testing has changed from strong to weak, and the changes in the IVD industry and the new situation 21 Economic Net

Investment hedging guide: U.S. inflation data in April exceeded expectations, Tonghua Jinma will welcome a large-scale lifting of the ban, and Poly Development’s April contract amount decreased by 40% year-on-year

Stock Sea Navigation May 12 Shanghai and Shenzhen Stock Market Announcement Prompt Stock Sea Navigation_Sina Finance_Sina.com

Dirui Medical has terminated the repurchase and has repurchased 1.05% of the shares for 50 million yuan. The transaction price of Dirui Medical's total amount jqknews

The latest express delivery of major announcements of listed companies in Shanghai and Shenzhen on the evening of May 11_Shenzhen Hotline

Highlights of the announcement on the evening of May 11: PICC’s three subsidiaries’ original insurance premium income totaled 276.159 billion yuan in the first four months

Dirui Medical (300396.SZ) shareholder Yi Xiangping and others plan to reduce their holdings by no more than 3% IT News

Listed company evening announcement express on May 11_Sina Finance_Sina.com

ST Longjing: The company’s controlling shareholder plans to change to Zijin Mining; Longbai Group: Raise the prices of some of the company’s products – yqqlm

The latest announcement of Dirui Medical: It plans to terminate the repurchase of the company's shares and has repurchased 1.05% of the shares.

Dirui Medical: The implementation of share repurchase has completed the early termination of share repurchase matters_ Securities Times Network

Kunming Pharmaceutical Group plans to expand its listing platform to 17 by "adding Ding" to China Resources, the leader of Panax notoginseng

Kunpharm Group plans to change its ownership by 2.9 billion, and China Resources, the leader of Panax notoginseng, will expand its listing platform to 17 Kunpharm Group.

China Resources 392.9 billion won the controlling stake of Kunming Pharmaceutical Group

China Resources 392.9 billion won the controlling stake of Kunming Pharmaceutical Group

"Huali Department" exit: China Resources Sanjiu plans to take charge of Kunming Pharmaceutical Group with 2.902 billion yuan before the suspension of trading. Kunming Pharmaceutical Group

Dirui Medical: 14 institutions including Deyuan An Asset and Gaolan Investment investigated our company on May 5_Shenzhen Hotline

[News] Dirui Medical Announces Annual Report CFi.CN

On the evening of April 28, Shanghai and Shenzhen listed companies announced the latest express of major events_ Oriental Fortune Net

Dirui Medical: The company's new crown antigen detection product is being registered IT News

Want to see more data? Registered subscribers can see all the data.